BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2020 5:45:32 AM | Browse: 716 | Download: 1953
 |
Received |
|
2020-04-10 15:00 |
|
Peer-Review Started |
|
2020-04-10 15:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-09-21 18:28 |
|
Revised |
|
2020-10-29 16:31 |
|
Second Decision |
|
2020-11-11 08:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-11-12 16:52 |
|
Articles in Press |
|
2020-11-12 16:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-11-26 03:08 |
|
Typeset the Manuscript |
|
2020-12-11 03:56 |
|
Publish the Manuscript Online |
|
2020-12-13 05:45 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Observational Study |
| Article Title |
Diabetic patients with COVID-19 need more attention and better glycemic control
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ming Xu, Wen Yang, Tao Huang and Jun Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jun Zhou, MD, Surgeon, Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, China. doctorzhoujun@163.com |
| Key Words |
Diabetes; COVID-19; Comorbidity; Severity; Glycemic control; Hepatic dysfunction |
| Core Tip |
Type 2 diabetes is one of the most common comorbidities in coronavirus disease 2019 (COVID-19) patients. It is reported to be related to poorer prognosis in other infectious diseases. However, the role of diabetes in COVID-19, a newly pandemic disease, is not clearly investigated. We indicate that diabetes and hepatic dysfunction are risk factors for COVID-19 severe patients. Given that the blood glucose of patients with diabetes and COVID-19 is poorly controlled, glycemic management in COVID-19 patients needs to be optimized. |
| Publish Date |
2020-12-13 05:45 |
| Citation |
Xu M, Yang W, Huang T, Zhou J. Diabetic patients with COVID-19 need more attention and better glycemic control. World J Diabetes 2020; 11(12): 644-653 |
| URL |
https://www.wjgnet.com/1948-9358/full/v11/i12/644.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v11.i12.644 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
